Table 3 Relationship between TMED9 expression and clinicopathological features in 182 patients with hepatocellular carcinoma (HCC)

Age, years (mean ± SD)

61.7 ± 11.0

60.85 ± 13.65

Gender

 Male

83

72

 Female

15

12

AFP (ng/mL)

  < 400

79

63

  ≥ 400

17

20

 Unknown

2

1

Stage

 I + II

72

57

 I II

26

27

HBV

 Negative

35

26

 Positive

60

58

 Unknown

3

0

HCV

 Negative

63

67

 Positive

33

16

 Unknown

2

1

Recurrence status

 No

26

17

 Yes

72

67

Liver cirrhosis

 No

51

45

 Yes

41

38

 Unknown

6

1

Tumor size (cm)

  < 5

57

47

  > 5

41

37

Tumor numbers

 Solitary

57

48

 Multiple

41

36

Hepatic vein invasion

 No

95

74

 Yes

2

8

 Unknown

1

2

Portal vein invasion

 No

89

72

 Yes

7

11

 Unknown

2

1